Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-21-031465
Filing Date
2021-06-08
Accepted
2021-06-08 16:30:22
Documents
2
Period of Report
2020-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea142391-8ka1_abvcbiopharma.htm 8-K/A 20740
2 AMENDMENT NO. 1 TO PROMISSORY NOTE ea142391-ex10_3abvcbiopharma.htm EX-10.3 17510
  Complete submission text file 0001213900-21-031465.txt   39789
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-91436 | Film No.: 211002472
SIC: 2834 Pharmaceutical Preparations